For example, in hepatocellular carcinoma (HCC), downregulation of CBS is associated with disease severity and the CBS promoter is methylated in HCC, gastric, and colorectal carcinoma preventing expression [70,73,81,92]. Here, CBS is linked to hepatocellular carcinoma.